PRINCESS UKACHUKWU: Open Payments
NPI 1255619078 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 147 payments from 15 companies in 2025. Trend: 2023 $423 · 2024 $936 · 2025 $1,962
Food & beverage: $1,962
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 53 | $631 |
| SCILEX PHARMACEUTICALS INC. | 50 | $357 |
| Ardelyx, Inc. | 18 | $303 |
| Astellas Pharma US Inc | 7 | $192 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| ViiV Healthcare Company | 3 | $83 |
| Amgen Inc. | 1 | $76 |
| Valinor Pharma, LLC | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
Products named: RELISTOR, IBSRELA, ZTLido, Veozah, ELYXYB - CELECOXIB, TRELEGY ELLIPTA, DOVATO, MOVANTIK.
Industry payments across NY — which companies pay providers there.
